Blood and bone marrow cell study in heart bypass surgery patients
Part of Heart & circulation clinical trials.
This study looks at certain blood and bone marrow cells (megakaryocytes) in people having heart bypass surgery. It aims to learn more about these cells, which may help in future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for a planned (not emergency) heart bypass surgery that involves opening the chest.
- You have health insurance coverage.
- You are able to understand the study's purpose and what it involves.
- You are not pregnant or breastfeeding.
- You do not have certain blood disorders, a history of stem cell or organ transplant, active cancer, or have not had chest radiation therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving back a patient's own platelets and red blood cells during heart surgery can reduce bleeding and the need for donor blood transfusions. It is for people having certain types of high-risk heart surgery with a heart-lung machine.
This study looks at how different oxygen levels during heart bypass surgery might affect recovery. It aims to see if keeping oxygen at a certain level can improve outcomes for people having surgery where a vein from the leg is used to bypass a blocked heart artery.
This study looks at tiny structures inside heart muscle cells (especially “power stations” in the cells) in people with certain types of heart failure who are getting coronary bypass surgery. It may help researchers better understand what changes happen in the heart and how this could guide future care.
This trial tests whether collecting and re-infusing your own blood during heart surgery reduces the need for donor blood transfusions. It's for adults having planned bypass surgery with a heart-lung machine.
This study tests a new treatment using donor stem cells injected into the heart during scheduled bypass surgery. The goal is to see if these cells help improve heart function in people with heart failure due to blocked arteries and a weak heart pump.
This study looks at how blood cells change during heart surgery and whether these changes affect bleeding or inflammation after the operation. It may help doctors predict and manage complications in people having heart surgery.
Hear when a new Cardiac Surgery for Bypass Grafting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.